Generic Liraglutide — Overlooked but Not Forgotten
New England Journal of Medicine · 08.01.2026 · 394 (2) · 107-110
DOI: 10.1056/nejmp2515668 ↗Kurz gefasst
Fachartikel in der Zeitschrift New England Journal of Medicine, erschienen am 08.01.2026. Verfasst von Suhas Gondi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Massachusetts General Hospital, Boston. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medicine, Massachusetts General Hospital, Boston.
- Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston.
ORCID-Profile: Benjamin N Rome
Zitieren
APA
Gondi, S., Kesselheim, A. S., & Rome, B. N. (2026). Generic Liraglutide — Overlooked but Not Forgotten. New England Journal of Medicine, 394(2), 107-110. https://doi.org/10.1056/nejmp2515668
Vancouver
Gondi S, Kesselheim AS, Rome BN. Generic Liraglutide — Overlooked but Not Forgotten. New England Journal of Medicine. 2026;394(2):107-110. doi:10.1056/nejmp2515668
BibTeX
@article{Gondi2026,
author = {Gondi, Suhas and Kesselheim, Aaron S and Rome, Benjamin N},
title = {Generic Liraglutide — Overlooked but Not Forgotten},
journal = {New England Journal of Medicine},
year = {2026},
volume = {394},
number = {2},
pages = {107--110},
doi = {10.1056/nejmp2515668}
}
EUVIMED